Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports|August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroidMaximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One|June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreasRia Uhlig, Nina Bröker, Sören Weidemann, et al.
Diagnostics (Basel, Switzerland)|October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 TumorsFlorian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Biomedicines|December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed ImmunohistochemistryTim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
Plos One|July 21, 2022
High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical TissueMaximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Pageof 17